1. Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer
   Kyu Sic You et al, 2021, Pharmaceuticals CrossRef
2. Network controllability solutions for computational drug repurposing using genetic algorithms
   Victor-Bogdan Popescu et al, 2022, Sci Rep CrossRef
3. Nucleus Near-Infrared (nNIR) Irradiation of Single A549 Cells Induces DNA Damage and Activates EGFR Leading to Mitochondrial Fission
   Momoh Gbetuwa et al, 2022, Cells CrossRef
4. Synthesis, docking study, and structure activity relationship of novel anti-tumor 1, 2, 4 triazole derivatives incorporating 2-(2, 3- dimethyl aminobenzoic acid) moiety
   Hiba Alsaad et al, 2022, PHAR CrossRef
5. Molecular basis of epigenetic regulation in cancer diagnosis and treatment.
   Sonam Tulsyan et al, 2022, Front Genet CrossRef
6. Click Chemistry-Generated Auristatin F–Linker–Benzylguanine for a SNAP-Tag-Based Recombinant Antibody–Drug Conjugate Demonstrating Selective Cytotoxicity toward EGFR-Overexpressing Tumor Cells
   Allan M. Huysamen et al, 2023, ACS Omega CrossRef
7. Epidermal growth factor receptor inhibition potentiates chemotherapeutics‐mediated sensitization of metastatic breast cancer stem cells
   Trisha Kar et al, 2024, Cancer Reports CrossRef
8. Aptamer-guided Selective Delivery of Therapeutics to Breast Cancer Cells Expressing Specific Biomarkers
   Swaroop Kumar Pandey et al, 2024, CCTR CrossRef
9. Recent update on IGF-1/IGF-1R signaling axis as a promising therapeutic target for triple-negative breast cancer
   Shashank Kumar et al, 2024, Pathology - Research and Practice CrossRef